J&J Is Being Disciplined by Abandoning Merger Talks With Actelion, Jim Cramer Says
Jim Cramer comments on Johnson & Johnson's move to abandon merger talks with Actelion.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer comments on Johnson & Johnson's (JNJ) - Get Report move to abandon merger talks with Actelion. "One of the reasons [Johnson & Johnson] has that great balance sheet is because they don't overpay," Cramer said. The cause for the failed talks was pricing, according to the Wall Street Journal and the deal may have been worth upwards of $30 billion. Reports suggest Sanofi (SNY) - Get Report is in merger talks with Actelion. Cramer spoke earlier from the floor of the New York Stock Exchange.
